Log In
Print this Print this

Iressa, gefitinib

Also known as: ZD1839

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionEGFR kinase inhibitor
Molecular Target Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1)
Mechanism of ActionEpidermal growth factor (EGF) receptor kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today